We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Metabolite Detection Method Using DNA Sequencing Could Transform Diagnostics

By LabMedica International staff writers
Posted on 05 Feb 2025

Metabolites play a vital role as biomarkers that provide insights into our health, and when their levels go awry, it can lead to diseases such as diabetes and phenylketonuria. More...

Quantifying metabolites remains challenging due to their biochemical diversity, making them difficult to amplify using methods like PCR. The major hurdle in metabolomics is to efficiently measure a broad range of molecules across various samples, such as tissues, plasma, or single cells, rapidly and effectively. Researchers have now created a method that leverages DNA sequencing to measure metabolite or drug levels, thus incorporating the capabilities of DNA sequencing into metabolomics.

The new DNA sequencing-based approach for metabolite measurement was developed by scientists at the University of Toronto (Ontario, Canada), and their findings were published in Nature Biotechnology. This method facilitates the swift and precise analysis of biological compounds, including sugars, vitamins, hormones, and numerous other metabolites crucial to health. The novel platform for small molecule sequencing, named “smol-seq,” utilizes short DNA sequences called aptamers to detect metabolites. Each aptamer is specifically engineered to bind to a target metabolite and carry a unique DNA barcode. When an aptamer binds to its designated target, the aptamer’s structure changes and releases its DNA barcode. For instance, an aptamer designed to detect glucose releases one barcode, while an aptamer targeting the stress hormone cortisol releases a distinct barcode. By sequencing these released barcodes, researchers can determine which aptamers have successfully found their targets. The more of a metabolite present in the sample, the more barcodes are released, providing a way to measure the concentration of various molecules within a mixture.

Although aptamers have been previously used to measure metabolites, those methods generally only allowed the measurement of a limited number of metabolites at once. The researchers recognized that by using DNA barcodes as tags for metabolites, they could measure hundreds or even thousands of metabolites simultaneously. With the smol-seq platform now operational, the next phase is to develop aptamers for metabolites with potential biomedical significance. Over time, the expanding aptamer database will support machine learning approaches for predicting new aptamer designs capable of binding novel metabolite targets. In addition to enhancing the aptamer database, the research team will refine the platform to improve the precision of aptamer binding. This will be achieved by fine-tuning aptamer development at the nucleic acid level, ensuring the specificity required as the platform’s capacity to study an increasing number of metabolites grows.

“DNA sequencing is millions of times faster than it was 20 years ago, and we wanted to harness that power for metabolite detection,” said Andrew Fraser, principal investigator on the study and professor of molecular genetics at U of T’s Temerty Faculty of Medicine. “Smol-seq could transform diagnostics and biotechnology by making metabolite detection as easy and rapid as DNA sequencing.”


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.